{
    "organizations": [],
    "uuid": "ad8585dcbd435949a37ca20f52ace9329c1cfd93",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncoarendi-therapeutics-consolidat/brief-oncoarendi-therapeutics-consolidated-fy-net-loss-flat-at-2-4-mln-zlotys-idUSFWN1S31MV",
    "ord_in_thread": 0,
    "title": "Oncoarendi Therapeutics Consolidated FY Net Loss Flat At 2.4 Mln Zlotys",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - ONCOARENDI THERAPEUTICS SA:\n* CONSOLIDATED FY NET LOSS FLAT AT 2.4 MILLION ZLOTYS * CONSOLIDATED FY OPERATING REVENUE AT 1.5 MILLION ZLOTYS VERSUS 1.6 MILLION ZLOTYS YEAR AGO Source text for Eikon: (Gdynia Newsroom)\n ",
    "published": "2018-04-26T23:35:00.000+03:00",
    "crawled": "2018-04-27T17:01:00.064+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "oncoarendi",
        "therapeutic",
        "sa",
        "consolidated",
        "fy",
        "net",
        "loss",
        "flat",
        "million",
        "zloty",
        "consolidated",
        "fy",
        "operating",
        "revenue",
        "million",
        "zloty",
        "versus",
        "million",
        "zloty",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "gdynia",
        "newsroom"
    ]
}